IPP Bureau
Sapio announces the first web-based bioanalysis LIMS solution
By IPP Bureau - March 16, 2022
This pre-packaged release is a ready-to-go solution with powerful, straightforward bioanalysis pipeline support
Experts call for capacity building to combat Antimicrobial Resistance
By IPP Bureau - March 16, 2022
The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific
Unichem receives ANDA approval for hypertension drug
By IPP Bureau - March 16, 2022
Nebivolol is used alone or together with other medicines to treat high blood pressure
Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA
By IPP Bureau - March 16, 2022
The USFDA has granted a qualified infectious disease product (QIDP) designation to WCK 6777, which signifies its ability to meet unmet medical needs and facilitates a faster approval process
Sanofi announces €300 million collaboration with Blackstone Life Sciences
By IPP Bureau - March 16, 2022
The investment will accelerate the overall Sarclisa development program
Jeffrey W. Fisher is the recipient of the Arnold J Lehman SOT award
By IPP Bureau - March 16, 2022
Career achievement for contributions in Physiologically based pharmacokinetic (PBPK) and biologically based does response (BBDR) modelling tools
IQVIA launches OCE+ to deliver AI-driven customer engagement
By IPP Bureau - March 16, 2022
OCE+ uses IQVIA’s industry-leading data and advanced analytics to deliver AI-driven recommendations directly into the daily workflows of life sciences commercial teams
Oppilotech and Evariste technologies partner for anti-bacterial programme
By IPP Bureau - March 16, 2022
Machine learning approach to systems biology combined with ligand discovery platform
UFDA approves first generic of Symbicort to treat asthma and COPD
By IPP Bureau - March 16, 2022
This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)
Onco aims to make cancer care affordable
By IPP Bureau - March 16, 2022
Onco Care Plus is available at just INR 399 per month, and provides services like free doctor consultation, 15% off on cancer treatment costs, 25% off for diagnostic tests, free nutrition plans, among many more
Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates
By IPP Bureau - March 16, 2022
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
Bharat Biotech and Biofabri to develop and distribute novel TB vaccine
By IPP Bureau - March 16, 2022
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
SRL Diagnostics and Roche Diagnostics partner to establish an integrated lab
By IPP Bureau - March 16, 2022
Empowers the lab to do more in less time within the existing floor plan by integrating clinical chemistry and immunoassay testing onto a single platform
Boston Scientific opens second R&D centre in Pune
By IPP Bureau - March 16, 2022
The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300
BSV invests in solar power project as part of it sustainability commitment
By IPP Bureau - March 16, 2022
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
